Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ: ILMN )

84.05 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
US Stocks To Open Higher Ahead Of Fed's Decision This Week: Analyst Says 'Santa Comes Later In December'
U.S. stock futures were trading higher after the Nasdaq 100 extended its relentless climb last week, nearing the 22,000-point milestone. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Palantir Stock Is Joining the Nasdaq-100 Index, and Super Micro Computer Is Being Booted: What Investors Should Know
Palantir stock's huge rise this year has earned it a spot on another stock index. 
Via The Motley Fool
GRAIL: Biotech Stock Targeting $100B Cancer Market
GRAIL is a small biotech stock on the rise big time recently. Its innovative technology gives it the opportunity to capitalize on a massive addressable market. 
Via MarketBeat
Topics Death
Exposures Death
MicroStrategy, Palantir, Axon Added To Nasdaq 100: Super Micro Computer, Moderna, Illumina Exit The Index
The much-awaited reconstitution of the Nasdaq 100 index has taken place, resulting in the addition of Bitcoin (CRYPTO: BTC) proxy MicroStrategy Inc. (NASDAQ:MSTR), Palantir Technologies Inc. (NASDAQ: 
Via Benzinga
CD Genomics Enhances Whole Genome SNP Genotyping Services to Propel Genomic Discoveries
Via Press Release Distribution Service
Looking Into Illumina's Recent Short Interest
Via Benzinga
This D.R. Horton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
Agreement will expand worldwide access and better position Myriad’s GIS as a potential companion diagnostic across multiple potential tumor types 
From Myriad Genetics, Inc.
Via GlobeNewswire
Smaller Cap Biotechs Are In Season: How Are We Doing?
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,600 Today
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $4,600 Today
Via Benzinga
Decoding 14 Analyst Evaluations For Illumina
Via Benzinga
How Is The Market Feeling About Illumina?
Via Benzinga
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
Wall Street rallied on Tuesday as improved investor sentiment aligned with millions of Americans casting their votes for the 47th president. 
Via Benzinga
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday. 
Via Benzinga
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $38,000 Today
Via Benzinga
Peering Into Illumina's Recent Short Interest
Via Benzinga
Biotech Momentum Trades For The Q4 Rally
The biotech sector made an interim peak in late February followed by an active summer in very choppy trading. 
Via Talk Markets
This Illumina Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
Biotech Stocks Poised For Another Big Move In Q4
The healthcare sector can be a safe haven if volatility increases. 
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine
Illumina welcomes the European Court of Justice ruling that the European Commission lacked jurisdiction over its acquisition of GRAIL, confirming Illumina's stance. The ruling nullifies a €432 million... 
Via Benzinga
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $47,000 Today
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 31
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Aug. 26-30, 2024. 
Via Talk Markets
S&P 500, Nasdaq 100 Extend 8-Session Winning Streak As Wall Street Jitters 'Go Poof': Monday's Key Stock Movers
Via Benzinga
Topics Stocks
Exposures US Equities
This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Via Benzinga
This Cisco Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga
Alibaba To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.